中华老年医学杂志2024,Vol.43Issue(9) :1216-1221.DOI:10.3760/cma.j.issn.0254-9026.2024.09.020

PI3K-Akt信号通路在肌少症中的作用研究进展

Research progress on the role of the PI3K-AKT signaling pathway in sarcopenia

陈凤 桂明 赵丽娟
中华老年医学杂志2024,Vol.43Issue(9) :1216-1221.DOI:10.3760/cma.j.issn.0254-9026.2024.09.020

PI3K-Akt信号通路在肌少症中的作用研究进展

Research progress on the role of the PI3K-AKT signaling pathway in sarcopenia

陈凤 1桂明 1赵丽娟1
扫码查看

作者信息

  • 1. 中南大学湘雅三医院肾病风湿科,长沙 410013
  • 折叠

摘要

肌少症是一种进行性骨骼肌质量和功能减退的综合征,其发病风险随着年龄的增长而增加.目前已成为老年人临床疾病之一,然而该病分子机制尚不清楚,治疗策略的选择和疗效评价也不同.近年来,研究者从营养、运动、遗传等因素上寻找机制,PI3K-Akt信号通路作为其中的调节通路之一,目前发现其与多种因素有关,本综述将主要阐述细胞因子、激素、促炎因子、线粒体在该通路上对肌少症中的调控机制,希望为肌少症的治疗提供新线索.

Abstract

Sarcopenia is a progressive disease characterized by the loss of skeletal muscle mass and function.The risk of developing sarcopenia increases with age,making it a significant clinical concern for the elderly.However,the molecular mechanism underlying this disease remains unclear,and there is a lack of consensus regarding treatment strategies and evaluation of their effectiveness.In recent years,researchers have explored various factors such as nutrition,exercise,and genetics to understand the mechanisms involved.One such regulatory pathway,the PI3K-Akt signaling pathway,has been found to be associated with multiple factors.This review aims to shed light on the regulatory mechanisms of cytokines,hormones,pro-inflammatory factors,and mitochondria within this pathway in the context of sarcopenia.By doing so,it hopes to offer new insights for the treatment of sarcopenia.

关键词

肌少症/PIBK-AKt信号通路/骨骼肌

Key words

Sarcopenia/PI3K-Akt signaling pathway/Skeletal muscle

引用本文复制引用

出版年

2024
中华老年医学杂志
中华医学会

中华老年医学杂志

CSTPCD北大核心
影响因子:1.606
ISSN:0254-9026
段落导航相关论文